91AV原创

Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Tavneos was launched in Japan in June 2022 after receiving approval from the health ministry. Its package insert listed liver dysfunction as a serious side effect.
JAPAN / Science & Health
Oct 22, 2026
Health ministry questions reliability of vasculitis drug approval data
Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.
Boxes of medicine move along conveyor belts at Toho Pharmaceutical's distribution center in Kuki, Saitama Prefecture. Japan has increasingly positioned the drug industry as a strategic sector, citing its importance to economic security and future growth.
COMMENTARY / Japan / Geoeconomic Briefing
Oct 5, 2026
Japan wants a pharma boom. It needs a new strategy.
Japan is seeking to make pharmaceuticals a pillar of economic growth and security, requiring innovation and manufacturing capacity.
A Kobayashi Pharmaceutical factory in Osaka. Kobayashi’s shares have languished since a supplement scandal came to light in early 2024 and remain about 13% below levels seen before the incident.
BUSINESS / Companies
Sep 25, 2026
Kobayashi in ?500 billion buyout talks after red-yeast case
CVC Capital Partners and Nippon Sangyo Suishin Kiko are weighing a bid to take the company private, sources said.
 Alzheimer's drug Lecanemab
JAPAN / Science & Health
Sep 21, 2026
Clinical trials for Alzheimer’s treatment face global shortage of participants
The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer’s Disease International warns.
Under a new system for prescription drugs that are similar to over-the-counter medicines, patients will pay 25% of the prices of drugs that can be substituted with OTC drugs.
JAPAN / Science & Health
Sep 17, 2026
Some patients to be exempted from additional drug payments
Those with rare diseases and under prolonged treatment won’t have to pay extra for prescription drugs that are similar to over-the-counter medicines.
BioNTech said its experimental drug gotistobart nearly doubled the median survival of patients with an aggressive form of lung cancer compared to chemotherapy.
WORLD
Sep 14, 2026
BioNTech lung cancer drug extends survival versus chemotherapy
Patients treated with gotistobart lived for a median 18.5 months, compared with 10 months for those given the standard-of-care chemotherapy.
Yasuchika Hasegawa, former president of Takeda Pharmaceutical and former chair of the Japan Association of Corporate Executives
JAPAN
Sep 11, 2026
Former head of Takeda Pharmaceutical dies at 80
As president of Takeda Pharmaceutical, Yasuchika Hasegawa paved the way for the company to go global.
Masashi Yanagisawa, a professor at University of Tsukuba, won the basic medical research category of the Lasker Awards for his role in identifying orexin, a brain peptide that maintains wakefulness.
JAPAN / Science & Health
Sep 10, 2026
Four Japanese scientists win prestigious U.S. Lasker Awards
One received the prize for his work on a sleep-regulating brain chemical, and a trio, for discovering an antibody therapy for hemophilia A patients.
Insilico Medicine CEO Alex Zhavoronkov
WORLD / Science & Health
Sep 8, 2026
AI-discovered lung drug reverses aging markers in study
An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment, according to its developer.
A patient speaks with Dr. Sean Alemi, a New York-based facial plastic surgeon, after getting cosmetic surgery following GLP-1 weight-loss drugs.
WORLD / Science & Health
Sep 7, 2026
Beyond the scale: Men turn to cosmetic clinics to complete weight-loss transformation
As top-selling weight-loss drugs help more U.S. men slim down, a growing number are seeking cosmetic treatments for sagging skin, hair loss and dental issues to complete their physical transformation, patients and plastic surgeons say.
Taiane Torres da Silva, 32, who works at a pet shop, prepares a tirzepatide injection at home in Nova Iguacu, Brazil, on Aug. 17.
BUSINESS
Sep 1, 2026
Booming weight-loss drug demand in Brazil fuels thriving black market and health fears
Between 2018 and mid-August 2026, Brazilian authorities recorded 83 deaths, which are under investigation, and over 3,600 complications linked to weight-loss drugs.
Japan plans to introduce additional fees for OTC-equivalent prescription drugs in March next year.
JAPAN
Aug 31, 2026
Japan to exempt extra charges on OTC-like drugs from tax
Japan plans to introduce the additional fees for OTC-equivalent prescription drugs in March next year.
Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.
BUSINESS / Markets
Aug 31, 2026
Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine
Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.
Some clinics in Japan have prescribed sleeping pills and psychotropic medications while promoting the concept of "achieving beauty through quality sleep."
JAPAN
Aug 24, 2026
‘Beauty sleep’ treatments spark controversy in Japan
Some clinics have prescribed sleeping pills and psychotropic medications while promoting the concept of “achieving beauty through quality sleep.”
People walk past billboards from Innovent Biologics and Meituan displayed on a wall in a metro station in Shanghai on July 6.
BUSINESS / Companies
Aug 24, 2026
Snoring, subways and stealth ads: How big pharma targets China’s waistline
Local restrictions prevent drug companies from directly advertising prescription medicines in the world’s second-largest drug market.
Merck and Moderna said their personalized cancer vaccine helped prevent the return and spread of disease in a large trial involving more than 1,000 melanoma patients.
BUSINESS / Companies
Aug 20, 2026
Moderna and Merck’s breakthrough could usher in wave of cancer vaccines
The treatment involves pairing Merck’s immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.
The summer heat hits Tokyo's Ginza District on July 23.
JAPAN / Science & Health
Aug 17, 2026
60% in Japan give up activities due to sweat, survey finds
The most common changes respondents made amid sweltering heat included giving up their preferred clothing and avoiding approaching others.
Shionogi is looking for acquisition targets in the U.S., Japan and Europe that specialize in infectious and rare diseases, said Isao Teshirogi, Shionogi chairperson and CEO, in an interview on Tuesday.
BUSINESS / Companies
Aug 5, 2026
Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production
The pharmaceutical manufacturer wants to accelerate its overseas growth while broadening its portfolio beyond its traditional strength in infectious disease medications.
Novo Nordisk is getting a boost from its new Wegovy  weight-loss pill.
BUSINESS
Aug 3, 2026
Obesity battle heats up again as Novo claws its way back into race with Lilly
Novo Nordisk is getting a boost from its new Wegovy weight-loss pill that ?is holding onto its lead against Eli Lilly’s more recently launched Foundayo.
Incidents of health damage related to Kobayashi Pharmaceutical’s supplements were reported in 2024.
JAPAN
Jul 23, 2026
Japan to mandate reporting on supplement-linked health issues
The move comes on the heels of incidents related to Kobayashi Pharmaceutical’s supplements containing beni kо?ji red fermented rice.

Longform

Famima Park Azabudai is a concept store by FamilyMart that combines convenience store staples with branded apparel, merchandise and a landscaped outdoor space.
Convenience stores, toilets and the allure of everyday Japan

SUSTAINABLE JAPAN